Search research articles
Contact Us
Filters
Showing results (51-60 of 65) with videos related to
Page
of 7
Sort By:
Scientific Reports
|
April 18, 2025
Development of a novel family of antifungal agents based on a quinone methide oxime framework
Monika Janeczko, Maciej Masłyk, Oleg M Demchuk, et al.
European Journal of Medicinal Chemistry
|
March 29, 2016
Novel optimization of valmerins (tetrahydropyrido[1,2-a]isoindolones) as potent dual CDK5/GSK3 inhibitors
Aziz Ouach, Rajâa Boulahjar, Christine Vala, et al.
European Journal of Medicinal Chemistry
|
October 16, 2012
Synthesis and biological evaluation of new 5-benzylated 4-oxo-3,4-dihydro-5H-pyridazino[4,5-b]indoles as PI3Kα inhibitors
Amélie Bruel, Cédric Logé, Marie-Ludivine de Tauzia, et al.
Antimicrobial Agents and Chemotherapy
|
February 24, 2016
From Drug Screening to Target Deconvolution: a Target-Based Drug Discovery Pipeline Using Leishmania Casein Kinase 1 Isoform 2 To Identify Compounds with Antileishmanial Activity
Emilie Durieu, Eric Prina, Olivier Leclercq, et al.
European Journal of Medicinal Chemistry
|
September 19, 2015
Synthesis, antileishmanial activity and cytotoxicity of 2,3-diaryl- and 2,3,8-trisubstituted imidazo[1,2-a]pyrazines
Pascal Marchand, Marc-Antoine Bazin, Fabrice Pagniez, et al.
Molecules (Basel, Switzerland)
|
November 16, 2018
From Quinoxaline, Pyrido[2,3-<i>b</i>]pyrazine and Pyrido[3,4-<i>b</i>]pyrazine to Pyrazino-Fused Carbazoles and Carbolines
Frédéric Lassagne, Timothy Langlais, Elsa Caytan, et al.
Anti-Cancer Agents in Medicinal Chemistry
|
December 9, 2016
Discovery of New Aminosubstituted Pyrrolopyrimidines with Antiproliferative Activity Against Breast Cancer Cells and Investigation of their Effect Towards the PI3Kα Enzyme
Konstantinos Daniilides, Nikolaos Lougiakis, Thomas Evangelidis, et al.
Bioorganic & Medicinal Chemistry
|
January 10, 2021
Discovery of DB18, a potent inhibitor of CLK kinases with a high selectivity against DYRK1A kinase
Dabbugoddu Brahmaiah, Anagani Kanaka Durga Bhavani, Pasula Aparna, et al.
Molecules (Basel, Switzerland)
|
October 14, 2022
Structure Activity Relationship Studies around <i>DB18</i>, a Potent and Selective Inhibitor of CLK Kinases
Dabbugoddu Brahmaiah, Anagani Kanaka Durga Bhavani, Pasula Aparna, et al.
The Journal of Biological Chemistry
|
October 26, 2001
Lack of correlation between caspase activation and caspase activity assays in paclitaxel-treated MCF-7 breast cancer cells
Timothy J Kottke, April L Blajeski, X Wei Meng, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 65) with videos related to
Sort By:
Page
of 7
Scientific Reports
|
April 18, 2025
Development of a novel family of antifungal agents based on a quinone methide oxime framework
Monika Janeczko, Maciej Masłyk, Oleg M Demchuk, et al.
European Journal of Medicinal Chemistry
|
March 29, 2016
Novel optimization of valmerins (tetrahydropyrido[1,2-a]isoindolones) as potent dual CDK5/GSK3 inhibitors
Aziz Ouach, Rajâa Boulahjar, Christine Vala, et al.
European Journal of Medicinal Chemistry
|
October 16, 2012
Synthesis and biological evaluation of new 5-benzylated 4-oxo-3,4-dihydro-5H-pyridazino[4,5-b]indoles as PI3Kα inhibitors
Amélie Bruel, Cédric Logé, Marie-Ludivine de Tauzia, et al.
Antimicrobial Agents and Chemotherapy
|
February 24, 2016
From Drug Screening to Target Deconvolution: a Target-Based Drug Discovery Pipeline Using Leishmania Casein Kinase 1 Isoform 2 To Identify Compounds with Antileishmanial Activity
Emilie Durieu, Eric Prina, Olivier Leclercq, et al.
European Journal of Medicinal Chemistry
|
September 19, 2015
Synthesis, antileishmanial activity and cytotoxicity of 2,3-diaryl- and 2,3,8-trisubstituted imidazo[1,2-a]pyrazines
Pascal Marchand, Marc-Antoine Bazin, Fabrice Pagniez, et al.
Molecules (Basel, Switzerland)
|
November 16, 2018
From Quinoxaline, Pyrido[2,3-<i>b</i>]pyrazine and Pyrido[3,4-<i>b</i>]pyrazine to Pyrazino-Fused Carbazoles and Carbolines
Frédéric Lassagne, Timothy Langlais, Elsa Caytan, et al.
Anti-Cancer Agents in Medicinal Chemistry
|
December 9, 2016
Discovery of New Aminosubstituted Pyrrolopyrimidines with Antiproliferative Activity Against Breast Cancer Cells and Investigation of their Effect Towards the PI3Kα Enzyme
Konstantinos Daniilides, Nikolaos Lougiakis, Thomas Evangelidis, et al.
Bioorganic & Medicinal Chemistry
|
January 10, 2021
Discovery of DB18, a potent inhibitor of CLK kinases with a high selectivity against DYRK1A kinase
Dabbugoddu Brahmaiah, Anagani Kanaka Durga Bhavani, Pasula Aparna, et al.
Molecules (Basel, Switzerland)
|
October 14, 2022
Structure Activity Relationship Studies around <i>DB18</i>, a Potent and Selective Inhibitor of CLK Kinases
Dabbugoddu Brahmaiah, Anagani Kanaka Durga Bhavani, Pasula Aparna, et al.
The Journal of Biological Chemistry
|
October 26, 2001
Lack of correlation between caspase activation and caspase activity assays in paclitaxel-treated MCF-7 breast cancer cells
Timothy J Kottke, April L Blajeski, X Wei Meng, et al.
Page
of 7